Overview
News
Technologies
Salaries
Products
People
Jobs
Growth
Financials

Overview

Envision Pharma Group is a global, technology-enabled solutions partner for life sciences, uniting medical, commercial, and strategic expertise with AI-powered technology to help life sciences organizations deliver smarter, faster outcomes and real-world impact for patients.

News

News pharmexec.com 1 day ago
OKRA.ai Extends Collaboration with Bristol Myers Squibb PharmExec
Pharmaceutical Executive delivers strategic insights for pharma leaders, covering commercialization, market access, R&D, and leadership to drive success.
Read more
Report
News Eat This Not That 6 days ago
5 Restaurant Chains With the Best Fried Fish and Fried Okra, According to Diners
These popular restaurant chains serve the best fried fish and fried okra, according to online customer reviews.
Read more
Report
News foodandwine.com 18 days ago
Okra Fries Read more
Report
Blog 30 days ago
What actually moves the needle: Redefining patient advocacy impact measures
Biopharma organizations are investing more than ever in patient advocacy, but traditional methods to measure impact through reach, activity, and engagement alone no longer provide the complete picture. Many are adopting outcomes-focused approaches that de
Read more
Report
Award 1 month ago
Envision Pharma Group wins at the 2026 Communiqué Awards, with recognition across four categories
Envision Pharma Group has won Excellence in National or Local Education Meetings/Stand-Alone Events at the 2026 Communiqué Awards in London for its work on the Novartis MPN and CML Leaders Programme 2025, developed in partnership with Novartis UK. Envisio
Read more
Report
Blog 1 month ago
Whitepaper: Simulated advisory boards
Biopharma organizations across the development and commercialization continuum are often asked to make critical decisions before they have the benefit of a full external perspective. Questions around positioning, evidence strength, or differentiation do n
Read more
Report

Jobs

No jobs available at this time.